Comments*

 
  • Cell & Molecular Biology

  • Featured Event

    Green Buildings and Health: From the Lab to the Real World

    Wednesday, December 14, 2016 | 6:00 PM - 8:30 PM
    The New York Academy of Sciences

    Researchers at Harvard T.H. Chan School of Public Health and SUNY Upstate Medical University present the results of a new study showing that employees in high-performing, green-certified buildings had higher cognitive function test scores than those in similarly high-performing buildings that were not green certified, even after controlling for other potential explanatory factors.

  • Events 

    May 15 - 17, 2017

    13th International Conference on Myasthenia Gravis and Related Disorders

    Keynote Speaker: Vijay K. Kuchroo (Harvard Institutes of Medicine)

    Learn about most recent advances in basic, translational, and clinical research on the rare, acquired disorder, Myasthenia Gravis, as well as implications of this research on a range of related autoimmune and neuromuscular diseases.

    Wednesday, May 24, 2017 | 12:00 PM - 5:00 PM

    Chemical Biology Discussion Group Year-End Symposium

    Speakers: Sean F. Brady (The Rockefeller University), Dirk Trauner (New York University)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2017, the annual year-end meeting features keynote speakers Dr Sean F. Brady and Dr Dirk Trauner.

    Thursday, May 25, 2017 | 9:00 AM - 5:00 PM

    Targeting Cancer Metabolism and Signaling

    Keynote Speaker: Craig Thompson (Memorial Sloan Kettering Cancer Center)

    This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.

    Monday, June 5, 2017 | 12:30 PM - 5:30 PM

    2017 Ross Prize in Molecular Medicine — Regulating Immunity: Fc Receptor Biology

    Featuring: Jeffrey V. Ravetch (The Rockefeller University)

    The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine.

    June 13 - 14, 2017

    Neuroplasticity, Neuroregeneration, and Brain Repair

    Keynote Speaker: Michael V. Sofroniew (David Geffen School of Medicine at UCLA)

    The conference will explore neuroregenerative processes and identify strategies for translating knowledge into treatments for neurodegenerative diseases and nervous system injuries.

  • Past Events

    Tuesday, April 25, 2017 | 9:00 AM - 5:00 PM

    Complement Pathways in Disease

    Keynote Speaker: V. Michael Holers (University of Colorado School of Medicine)

    The complement system is the first line of defense against infection, however we have yet to capitalize on its therapeutic potential. This symposium will focus on novel insights into the complement pathway in a number of clinical disorders.

    Monday, April 10, 2017 | 1:30 PM - 4:30 PM

    Genome Integrity Discussion Group

    Speakers: Hironori Funabiki (The Rockefeller University), Tony Huang (NYU School of Medicine), Amy MacQueen (Wesleyan University), and Jessica Tyler (Weill Cornell Medical College)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Tuesday, March 21, 2017 | 12:00 PM - 5:00 PM

    Exosomes in the CNS

    Speakers: Tsuneya Ikezu (Boston University School of Medicine), David Issadore (University of Pennsylvania), Xandra Breakefield (Massachusetts General Hospital), Efrat Levy (NYU School of Medicine), Robert A. Rissman (University of California San Diego, School of Medicine), and Andrew West (The University of Alabama at Birmingham)

    In this symposium we will explore the contribution of extracellular vesicles to pathological processes underlying neurodegenerative disorders, and the appeal of exosomes as biomarkers and targets for the development of novel therapeutics.

    Wednesday, March 1, 2017 | 9:00 AM - 5:00 PM

    Quantitative Approaches in Immuno-Oncology

    Keynote Speaker: Harlan Robins (Fred Hutchinson Cancer Research Center)

    This symposium will explore the emerging field of quantitative immuno-oncology, covering the breadth of scientific topics and methods needed to quantify interactions between tumors and the immune system.

  • Publications 

    eBriefing

    Alzheimer's Disease as a Neurovascular Inflammatory Disorder

    Keynote Speaker: Costantino Iadecola (Weill Cornell Medicine)

    This eBriefing covers the basic research and clinical science elucidating such mechanisms that underlie the contribution of inflammatory pathways to vascular cognitive impairment and dementia.

    eBriefing

    Understanding Autophagy to Enhance Clinical Discovery: The 2016 Dr. Paul Janssen Award Symposium

    Featuring: Yoshinori Ohsumi (Tokyo Institute of Technology)

    In 2016, Yoshinori Ohsumi won the Nobel Prize for his ground-breaking research on autophagy, which demonstrated the crucial process it serves in maintaining cellular homeostasis, as well as established its role in human health. This eBriefing covers Ohsumi's presentation, in which he reflected on his initial work on the key players in autophagy and shared his vision for future advancements in the field. Following his award lecture, fellow prominent scientists at the forefront of autophagy research discussed emerging concepts and technologies, which are included as well.

    eBriefing

    Equivalence of Complex Drug Products: Scientific and Regulatory Challenges

    Organizers: Melanie Brickman Borchard (The New York Academy of Sciences), Alison Carley (The New York Academy of Sciences), Daan J.A. Crommelin (Utrecht University), Wenlei Jiang (US Food and Drug Administration), Scott McNeil (Nanotechnology Characterization Laboratory), Vinod Shah (Non Biological Complex Drugs Working Group), and Jon de Vlieger (Lygature)

    This eBriefing looks at approaches for complex drug development and regulation, outstanding challenges in the assessment of complex drug equivalence, consequences for product interchangeability, and comparisons of biological and non-biological complex drug families.

    Annals

    Special Issue: The Year in Evolutionary Biology

    Edited by Charles W. Fox (University of Kentucky) and Timothy A. Mousseau (University of South Carolina)

    Eleven scholarly review articles discuss topics in evolutionary biology and genetics